{"id":"F2007B01102","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 11 of 2004)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2004","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":67856,"registerId":"commonwealth-F2007B01102-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 11 of 2004)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85(2AA)\n\nNo. PB 11 of 2004\n\nI, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:\n\n1. This Declaration commences on 1 August 2004.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nCisapride Monohydrate\n\nDexamethasone with Framycetin Sulfate and Gramicidin\n\nDiclofenac Potassium\n\nErgotamine Tartrate with Caffeine\n\nHeparin Calcium\n\nPolygeline\n\nPolymyxin B Sulfate with Neomycin Sulfate and Gramicidin\n\nPolyvinyl Alcohol with Povidone\n\nPyridoxine Hydrochloride\n\nDated this twelfth day of July 2004.\n\nJOAN CORBETT\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Ageing\n\nDelegate of the Minister for Health and Ageing","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1088},"content_quality":"ok","complexity_score":2,"scope_assessment":{"changed":false,"description":"This is the original 2004 declaration. Its scope remains limited to the specific purpose of delisting nine named pharmaceutical products from Part VII of the National Health Act 1953, exactly as intended."},"complexity_factors":["Very short instrument with only 2 operative clauses","No nested conditional logic or exceptions","Simple structure: commencement date + list of removed items","Only references core sections of the parent Act (ss 85(2AA) and 85(2AB))","9 specific chemical entities listed in Schedule with no qualifying conditions"],"plain_english_summary":"This instrument removes nine specific medicines from Australia’s Pharmaceutical Benefits Scheme, so from 1 August 2004 those products ceased to be government‑subsidised. It primarily affects patients prescribed those drugs and the pharmacists who dispense them, who must now pay or charge full commercial prices. Removals were driven by safety concerns for some items and by low use, alternatives, or commercial decisions for others."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2004","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2004/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2004/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2004/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2004/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-11-of-2004/documents"}}